{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:53:18Z","timestamp":1793386398636,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jamda.2020.12.019","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T02:13:45Z","timestamp":1610936025000},"page":"1386-1395.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"Melina G.H.E.","family":"den Brok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"van Middelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"van Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Moll van Charante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-3390","authenticated-orcid":false,"given":"Edo","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2020.12.019_bib2","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2020.12.019_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2020.12.019_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.12.019_bib5","first-page":"1","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: A meta-analysis of individual participant data from prospective cohort studies","volume":"4422","author":"Ding","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib6","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: A systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.12.019_bib7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: A network meta-analysis","volume":"31","author":"Levi Marpillat","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2020.12.019_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/14656566.2017.1333599","article-title":"Treatment options and considerations for hypertensive patients to prevent dementia","volume":"18","author":"Hernandorena","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jamda.2020.12.019_bib9","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2020.12.019_bib10","author":"R\u00fccker"},{"key":"10.1016\/j.jamda.2020.12.019_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2020.12.019_bib12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.12.019_bib13","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jamda.2020.12.019_bib14","author":"Nelson"},{"key":"10.1016\/j.jamda.2020.12.019_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.12.019_bib16","author":"Wells"},{"key":"10.1016\/j.jamda.2020.12.019_bib17","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.12.019_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2020.12.019_bib20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.hjh.0000133730.47372.4c","article-title":"The Study on COgnition and Prognosis in the Elderly (SCOPE): Outcomes in patients not receiving add-on therapy after randomization","volume":"22","author":"Lithell","year":"2004","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2020.12.019_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2020.12.019_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2020.12.019_bib24","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.neurobiolaging.2014.05.002","article-title":"Use of diuretics is associated with reduced risk of Alzheimer\u2019s disease: The Cache County study","volume":"35","author":"Chuang","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jamda.2020.12.019_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bcp.12511","article-title":"Angiotensin receptor blockers and risk of dementia: Cohort study in UK Clinical Practice Research Datalink","volume":"79","author":"Goh","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2020.12.019_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/WNL.0000000000002946","article-title":"Dementia risk with antihypertensive use and blood pressure variability","volume":"87","author":"Tully","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2020.12.019_bib27","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/HJH.0000000000001411","article-title":"Lower dementia risk with different classes of antihypertensive medication in older patients","volume":"35","author":"Van Middelaar","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2020.12.019_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: The Baltimore Longitudinal Study of Aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jamda.2020.12.019_bib29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease Ginkgo Evaluation of Memory Study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2020.12.019_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-receptor blockers and risk of Alzheimer\u2019s disease in hypertension population\u2014A nationwide cohort study","volume":"77","author":"Hsu","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jamda.2020.12.019_bib31","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1253\/circj.CJ-16-0692","article-title":"Calcium-channel blockers and dementia risk in older adults\u2014National Health Insurance Service\u2013Senior Cohort (2002\u20132013)","volume":"80","author":"Hwang","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jamda.2020.12.019_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","article-title":"Antihypertensive drugs and incidence of dementia: The Rotterdam Study","volume":"22","author":"In\u2019t Veld","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jamda.2020.12.019_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.12.019_bib34","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archneur.58.10.1640","article-title":"Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study","volume":"58","author":"Morris","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11606-017-4281-x","article-title":"Antihypertensive medication and dementia risk in older adult African Americans with hypertension: A prospective cohort study","volume":"33","author":"Murray","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jamda.2020.12.019_bib36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: Results from the cardiovascular health study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2020.12.019_bib37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jamda.2017.11.017","article-title":"Antihypertensive medication regimen intensity and incident dementia in an older population","volume":"19","author":"Tan","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"8","key":"10.1016\/j.jamda.2020.12.019_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2018.02.027","article-title":"Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies","volume":"671","author":"Hussain","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jamda.2020.12.019_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-016-0673-2","article-title":"Relationship between antihypertensive medications and cognitive impairment: Part II. Review of physiology and animal studies","volume":"18","author":"Peters","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jamda.2020.12.019_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/HCO.0b013e3283620745","article-title":"Do angiotensin receptor blockers prevent Alzheimer\u2019s disease?","volume":"28","author":"Hajjar","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jamda.2020.12.019_bib42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: Progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2020.12.019_bib43","author":"Whelton"},{"key":"10.1016\/j.jamda.2020.12.019_bib44","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.12.019_bib45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib46","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2020.12.019_bib47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2020.12.019_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib49","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.hjh.0000133730.47372.4c","article-title":"The Study on COgnition and Prognosis in the Elderly (SCOPE): Outcomes in patients not receiving add-on therapy after randomization","volume":"22","author":"Lithell","year":"2004","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2020.12.019_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.jamda.2020.12.019_bib51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","article-title":"Antihypertensive drugs and incidence of dementia: The Rotterdam Study","volume":"22","author":"In\u2019t Veld","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jamda.2020.12.019_bib53","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archneur.58.10.1640","article-title":"Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study","volume":"58","author":"Morris","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: The Baltimore Longitudinal Study of Aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jamda.2020.12.019_bib55","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: Results from the cardiovascular health study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2020.12.019_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.12.019_bib57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-receptor blockers and risk of Alzheimer\u2019s disease in hypertension population\u2014A nationwide cohort study","volume":"77","author":"Hsu","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jamda.2020.12.019_bib58","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease Ginkgo Evaluation of Memory Study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2020.12.019_bib59","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.neurobiolaging.2014.05.002","article-title":"Use of diuretics is associated with reduced risk of Alzheimer\u2019s disease: The Cache County study","volume":"35","author":"Chuang","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jamda.2020.12.019_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bcp.12511","article-title":"Angiotensin receptor blockers and risk of dementia: Cohort study in UK Clinical Practice Research Datalink","volume":"79","author":"Goh","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2020.12.019_bib61","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1253\/circj.CJ-16-0692","article-title":"Calcium-channel blockers and dementia risk in older adults\u2014National Health Insurance Service\u2013Senior Cohort (2002\u20132013)","volume":"80","author":"Hwang","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jamda.2020.12.019_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/WNL.0000000000002946","article-title":"Dementia risk with antihypertensive use and blood pressure variability","volume":"87","author":"Tully","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2020.12.019_bib63","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/HJH.0000000000001411","article-title":"Lower dementia risk with different classes of antihypertensive medication in older patients","volume":"35","author":"Van Middelaar","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2020.12.019_bib64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11606-017-4281-x","article-title":"Antihypertensive medication and dementia risk in older adult African Americans with hypertension: A prospective cohort study","volume":"33","author":"Murray","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jamda.2020.12.019_bib65","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jamda.2017.11.017","article-title":"Antihypertensive medication regimen intensity and incident dementia in an older population","volume":"19","author":"Tan","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2020.12.019_bib66","first-page":"1","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: A meta-analysis of individual participant data from prospective cohort studies","volume":"4422","author":"Ding","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2020.12.019_bib67","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2020.12.019_bib68","series-title":"Meta-Analysis With R","first-page":"187","article-title":"Network meta-analysis","author":"Schwarzer","year":"2015"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020310689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020310689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T19:09:42Z","timestamp":1718737782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861020310689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1525861020310689"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2020.12.019","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2020.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}